M.J.P. Arthur

512 total citations
9 papers, 429 citations indexed

About

M.J.P. Arthur is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, M.J.P. Arthur has authored 9 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hepatology, 3 papers in Epidemiology and 2 papers in Cancer Research. Recurrent topics in M.J.P. Arthur's work include Liver physiology and pathology (4 papers), Protease and Inhibitor Mechanisms (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). M.J.P. Arthur is often cited by papers focused on Liver physiology and pathology (4 papers), Protease and Inhibitor Mechanisms (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). M.J.P. Arthur collaborates with scholars based in United Kingdom, United States and Germany. M.J.P. Arthur's co-authors include John P. Iredale, P J Winwood, D. Blewett, M. C. Richardson, Eric J. Thomas, Alastair D. Burt, Michael Becka, William Rosenberg, M. Dawson and D.C. Davies and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

M.J.P. Arthur

9 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J.P. Arthur United Kingdom 6 283 227 80 68 56 9 429
Dirk Michels Germany 6 235 0.8× 218 1.0× 64 0.8× 62 0.9× 76 1.4× 8 417
K Tanikawa Japan 9 181 0.6× 121 0.5× 68 0.8× 43 0.6× 70 1.3× 22 366
A Tschuschner Germany 9 133 0.5× 142 0.6× 57 0.7× 62 0.9× 90 1.6× 16 421
Shuji Nambu Japan 9 232 0.8× 143 0.6× 121 1.5× 79 1.2× 108 1.9× 18 484
Ahmed Eid Israel 9 200 0.7× 156 0.7× 77 1.0× 23 0.3× 56 1.0× 22 433
Meyer zum Büschenfelde Kh Germany 10 175 0.6× 208 0.9× 39 0.5× 16 0.2× 57 1.0× 55 417
Kyuichi Tanikawa Japan 5 182 0.6× 183 0.8× 41 0.5× 28 0.4× 78 1.4× 6 341
Cindy K. Cheung Hong Kong 9 377 1.3× 332 1.5× 109 1.4× 16 0.2× 64 1.1× 13 509
Katrin Böttcher Germany 8 158 0.6× 181 0.8× 60 0.8× 32 0.5× 94 1.7× 17 382
Seiji Miyazoe Japan 9 394 1.4× 500 2.2× 49 0.6× 91 1.3× 156 2.8× 10 726

Countries citing papers authored by M.J.P. Arthur

Since Specialization
Citations

This map shows the geographic impact of M.J.P. Arthur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J.P. Arthur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J.P. Arthur more than expected).

Fields of papers citing papers by M.J.P. Arthur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J.P. Arthur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J.P. Arthur. The network helps show where M.J.P. Arthur may publish in the future.

Co-authorship network of co-authors of M.J.P. Arthur

This figure shows the co-authorship network connecting the top 25 collaborators of M.J.P. Arthur. A scholar is included among the top collaborators of M.J.P. Arthur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J.P. Arthur. M.J.P. Arthur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tanwar, Sudeep, Julie Parkes, Paul Trembling, et al.. (2013). 1368 FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. Journal of Hepatology. 58. S550–S550. 2 indexed citations
2.
Rosenberg, William, Alastair D. Burt, Stefan G. Hübscher, et al.. (2001). Serum markers predict liver fibrosis. Hepatology. 4 indexed citations
3.
Rosenberg, William, et al.. (2000). Automated assays of serum markers of liver fibrosis predict histological hepatic fibrosis.. UCL Discovery (University College London). 5 indexed citations
4.
Thomas, Eric J., et al.. (1996). Endocrinology and paracrinology. Molecular Human Reproduction. 2(1). 26–30. 23 indexed citations
5.
Iredale, John P., et al.. (1996). Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology. 110(3). 821–831. 297 indexed citations
6.
Arthur, M.J.P. & John P. Iredale. (1994). Hepatic Lipocytes, TIMP-1 and Liver Fibrosis. Journal of the Royal College of Physicians of London. 28(4). 363–363. 20 indexed citations
7.
Arthur, M.J.P.. (1994). Degradation of Matrix Proteins in Liver Fibrosis. Pathology - Research and Practice. 190(9-10). 825–833. 65 indexed citations
8.
Arthur, M.J.P. & D. Blewett. (1988). IFAT detection of IgG specific to toxoplasma in thoracic fluids from aborted lambs: evaluation on routine diagnostic submissions. Veterinary Record. 122(2). 29–31. 9 indexed citations
9.
Wilsmore, A.J., M. Dawson, M.J.P. Arthur, & D.C. Davies. (1986). The use of a delayed hypersensitivity test and long-acting oxytetracycline in a flock affected with ovine enzootic abortion. British Veterinary Journal. 142(6). 557–561. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026